chr3-37273555-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001410721.1(GOLGA4):c.182C>T(p.Ser61Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000283 in 1,512,854 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001410721.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GOLGA4 | NM_002078.5 | c.163-8403C>T | intron_variant | ENST00000361924.7 | NP_002069.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GOLGA4 | ENST00000361924.7 | c.163-8403C>T | intron_variant | 1 | NM_002078.5 | ENSP00000354486.2 |
Frequencies
GnomAD3 genomes AF: 0.00162 AC: 247AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000261 AC: 36AN: 138190Hom.: 0 AF XY: 0.000134 AC XY: 10AN XY: 74822
GnomAD4 exome AF: 0.000124 AC: 169AN: 1360620Hom.: 1 Cov.: 25 AF XY: 0.000106 AC XY: 71AN XY: 672958
GnomAD4 genome AF: 0.00170 AC: 259AN: 152234Hom.: 3 Cov.: 32 AF XY: 0.00168 AC XY: 125AN XY: 74450
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 05, 2021 | The c.182C>T (p.S61L) alteration is located in exon 3 (coding exon 3) of the GOLGA4 gene. This alteration results from a C to T substitution at nucleotide position 182, causing the serine (S) at amino acid position 61 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at